Treatment of MRSA-Positive Eye Discharge in Infant Post-VSD Closure

Critical Risk Assessment and Diagnostic Workup

The American College of Cardiology and Infectious Diseases Society of America recommend immediate systemic IV vancomycin therapy for infants with MRSA-positive eye discharge post-VSD closure, due to the high risk of endocarditis or bacteremia 1, 2
Blood cultures (at least 2 sets) should be obtained to rule out bacteremia, as recommended by the Infectious Diseases Society of America 1, 2
A complete sepsis evaluation, including CBC, CRP, and assessment for other metastatic foci, is necessary, as suggested by the Infectious Diseases Society of America 1
Conjunctival cultures should be obtained if not already done, as recommended by the American Academy of Ophthalmology 3

The Infectious Diseases Society of America recommends IV vancomycin as the mandatory first-line treatment for infants with MRSA-positive eye discharge post-VSD closure, with standard neonatal/infant dosing based on age and renal function, and therapeutic drug monitoring to achieve appropriate trough levels 1, 2
The treatment duration should be at least 2 weeks if bacteremia is confirmed without endocarditis, and 4-6 weeks if complicated bacteremia or endocarditis is present, as recommended by the Infectious Diseases Society of America 1, 2, 4
Topical vancomycin eye drops (compounded) should be added for the conjunctivitis, as recommended by the American Academy of Ophthalmology 3

Clindamycin may be considered as an alternative systemic option if vancomycin is contraindicated, with a dosage of 10-13 mg/kg/dose IV every 6-8 hours, max 40 mg/kg/day, as suggested by the Infectious Diseases Society of America 2, 4, 5
Linezolid may be considered for non-endovascular infections in neonates with susceptible isolates, as recommended by the Infectious Diseases Society of America 2

Daily clinical assessment is necessary until fever resolves and the infant is clinically stable, as recommended by the Infectious Diseases Society of America 1
Repeat blood cultures should be done at 48-72 hours to document clearance, as suggested by the Infectious Diseases Society of America 1
The American Academy of Pediatrics recommends avoiding oral antibiotics as initial therapy in high-risk scenarios, and avoiding TMP-SMX in the immediate neonatal period due to kernicterus risk 1, 2